Skip to content

Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation

Serum Antimullerian Hormone Levels in Patients Who Underwent Hypogastric Artery Ligation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03220594
Enrollment
90
Registered
2017-07-18
Start date
2017-03-20
Completion date
2017-09-29
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMH

Keywords

hypogastric artery, anti-mullerian hormone, ovarian reserve, postpartum

Brief summary

To observe the effects of hypogastric artery ligation on serum antimullerian hormone levels.

Detailed description

To measure and compare serum antimullerian hormone levels in patients who underwent hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy and postpartum control. The procedures performed as an emergency life saving method during delivery. The reasons for hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy were obstetric hemorrhage mainly uterine atony. The serum levels of antimullerian hormone were measured 6 months after the operations and compared with matching postpartum controls. Serum levels of FSH, LH, PRL and TSH were also measured 6 months after the operation. Further, antral follicle count measured along with the aforementioned blood tests.

Interventions

PROCEDUREhypogastric artery ligation

hypogastric artery ligation is the ligation of the internal iliac artery to stop bleeding related to obstetrics obstetric hemorrhage Hysterectomy is the removal of the uterus if bleeding can't stop by hypogastric artery ligation

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18- 40 years * no systemic or endocrine diseases * patients who had hypogastric artery ligation and/or hysterectomy * healthy postpartum patients as controls

Exclusion criteria

* history of chemotherapy and/or radiotherapy * Obese patients * patients with previous/present endometriosis * patients with PCOS

Design outcomes

Primary

MeasureTime frameDescription
Ovarian reserve6 monthsTo evaluate postoperative ovarian reserve using anti-mullerian hormones and other ovary related hormones including FSH,LH

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026